These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1838508)

  • 21. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 22. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholesterol awareness in selected states--Behavioral Risk Factor Surveillance, 1987.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Apr; 37(16):245-8. PubMed ID: 3128724
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric approach to prevention of coronary heart disease.
    Winter WE; Hardt NS
    J Fla Med Assoc; 1993 Oct; 80(10):679-83. PubMed ID: 8270900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial.
    Gotto AM
    JAMA; 1997 Feb; 277(7):595-7. PubMed ID: 9032169
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcomes of a worksite cholesterol education program over a 5-year period.
    Perovich SJ; Sandoval WM
    J Am Diet Assoc; 1995 May; 95(5):589-90. PubMed ID: 7722197
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluations.
    Montagne O; Vedel I; Durand-Zaleski I
    Clin Ther; 1999 Nov; 21(11):2027-35. PubMed ID: 10890271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [National program for cholesterol prevention in Poland. Individual strategy].
    Cybulska B; Szostak WB
    Wiad Lek; 1990 Aug 1-15; 43(15-16):796-807. PubMed ID: 2275201
    [No Abstract]   [Full Text] [Related]  

  • 30. Does estrogen therapy have a role in cardiovascular prevention?
    Newnham HH; Silberberg J
    Am Fam Physician; 1999 Mar; 59(5):1125-6, 1131. PubMed ID: 10088872
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular risk and hormone replacement therapy.
    Lawlor DA; Smith GD
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):658-65. PubMed ID: 17099339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prevention of CHD: nine ways to reduce risk.
    Havranek EP
    Am Fam Physician; 1999 Mar; 59(6):1455-63, 1466. PubMed ID: 10193589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient profile: primary prevention.
    Bruckert E
    Int J Clin Pract Suppl; 2002 Jul; (130):4-5. PubMed ID: 12296607
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary prevention: a simple, effective means of risk reduction.
    Gaw A
    Int J Clin Pract Suppl; 2002 Jul; (130):6-12. PubMed ID: 12296608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical trials for primary prevention of ischemic cardiopathy. Light and darkness].
    Dal Palù C; Zamboni S
    G Ital Cardiol; 1990 Nov; 20(11):1044-53. PubMed ID: 2090548
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 39. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
    Rossouw JE
    Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.